Fortification of breast milk with a very expensive product based on concentrated human milk does not improve the health of extremely preterm infants, compared to a standard fortifier. This is shown in a Swedish study of international interest, with the participation of Umeå, Linköping, Göteborg, Stockholm and Uppsala. Magnus Domellöf is in the steering committee […]

Premature babies routinely receive protein-enriched breast milk in order to grow and develop normally. This fortification is normally made from cow’s milk but there is a new fortification product on the market that is made from concentrated donated breast milk. This product (human milk-based fortifier, HMBF) is very expensive (costing >100,000 SEK per child) but […]

The N4 research group are starting up several new clinical trials in the autumn and winter of 2022. We plan to provide a brief introduction to each project over the coming months, and will start with ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA. GRANDIOSA is a blinded, placebo-controlled, randomized clinical trial […]

The neonatology department in Umeå has had a recent two-day research visit from staff of the Medical University in Vienna. Prof Magnus Domellöf helped put together a full programme for the four visitors; Christoph Binder (Consultant neonatologist, PhD), Alexandra Thajer (Associate professor/Senior Researcher), Theresa Kainz and Elisabeth Calek (Neo Residents, Nutrition Team). Dr Binder gave […]